Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(14)
MIXED(5)
Valsartan
2 trials
phase_2phase_4
vanderbilt-university
NHP544-C 81 mg
1 trial
not_applicable
vanderbilt-university
Sildenafil + L-NMMA + bradykinin
1 trial
not_applicable
vanderbilt-university
ramipril (ACE inhibitor)
1 trial
phase_3
vanderbilt-university
Sildenafil citrate
1 trial
phase_4
vanderbilt-university-medical-center
L-NMMA + bradykinin
1 trial
not_applicable
vanderbilt-university
Control (bradykinin)
1 trial
not_applicable
vanderbilt-university
Ramipril
1 trial
phase_2
vanderbilt-university

+10 more interventions

18 unique interventions2 categories

Analytics

Trial Phases

Phase 22
Phase 31
Phase 43

Trial Status

Completed7
Terminated1

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT03486223Phase 2Completed
Soluble Epoxide Hydrolase Inhibition and Insulin Resistance
Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders+2 more
PrincipalinvestigatorStart date: 2018-05-17
NCT00685945Not ApplicableCompleted
Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3
Obesity
Principalinvestigator
NCT00732069Phase 2Completed
Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
Complication of HemodialysisEnd Stage Renal Failure on Dialysis
Principalinvestigator
NCT00872599Phase 4Completed
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
Hypertension
Principalinvestigator
NCT00878969Phase 3Terminated
Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3
Endothelial DysfunctionOxidative Stress
Principalinvestigator
NCT02129725Phase 4Completed
Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.
Metabolic Syndrome
Principalinvestigator
NCT02189122Not ApplicableCompleted
Comparative Effects of Aspirin and NHP-544C
Healthy
Principalinvestigator
NCT02639637Phase 4Completed
Effect of DPP4 Inhibition on Vasoconstriction
Type 2 Diabetes Mellitus
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

James M Luther, MD

Vanderbilt University Medical Center

Similar
4 trials

Shared therapeutic areas:

Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders+3 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+3 more
Collaborated on 1 trial
Similarity Score64%

Jonathan Himmelfarb, MD

University of Washington

Related
5 trials

Shared therapeutic areas:

Endothelial DysfunctionOxidative Stress

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+2 more
Collaborated on 1 trial
Similarity Score24%

Talat A Ikilzer, MD

Vanderbilt University Medical Center

Related
1 trials

Shared therapeutic areas:

Endothelial DysfunctionOxidative Stress

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)University of Washington+1 more
Collaborated on 1 trial
Similarity Score24%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

HealthyHypertensionPrediabetic State+3 more
Similarity Score14%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

ObesityGlucose Metabolism DisordersMetabolic Syndrome+2 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+1 more
Similarity Score12%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityMetabolic SyndromeDiabetes Mellitus+1 more
Similarity Score9%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityHealthyDiabetes Mellitus+1 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score9%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Diabetes MellitusDiabetes Mellitus, Type 2Obesity
Similarity Score7%

Bruce Buckingham, MD

Stanford University

Related
24 trials

Shared therapeutic areas:

Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score7%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2HypertensionObesity
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT03486223Phase 2PrincipalInvestigator

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders+2 more
Completed
NCT00685945Not ApplicablePrincipalInvestigator

Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3

Obesity
Completed
NCT00732069Phase 2PrincipalInvestigator

Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

Complication of HemodialysisEnd Stage Renal Failure on Dialysis
Completed
NCT00872599Phase 4PrincipalInvestigator

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

Hypertension
Completed
NCT00878969Phase 3PrincipalInvestigator

Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

Endothelial DysfunctionOxidative Stress
Terminated
NCT02129725Phase 4PrincipalInvestigator

Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

Metabolic Syndrome
Completed
NCT02189122Not ApplicablePrincipalInvestigator

Comparative Effects of Aspirin and NHP-544C

Healthy
Completed
NCT02639637Phase 4PrincipalInvestigator

Effect of DPP4 Inhibition on Vasoconstriction

Type 2 Diabetes Mellitus
Completed

All 8 trials loaded